Millennium Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,000
Closed -$1.19M 5759
2025
Q4
$1.19M Buy
20,000
+5,600
+39% +$305K ﹤0.01% 4367
2025
Q3
$780K Buy
14,400
+1,100
+8% +$62.9K ﹤0.01% 4808
2025
Q2
$731K Buy
13,300
+6,600
+99% +$389K ﹤0.01% 4645
2025
Q1
$474K Sell
6,700
-1,600
-19% -$108K ﹤0.01% 4848
2024
Q4
$546K Sell
8,300
-60,400
-88% -$4.05M ﹤0.01% 4681
2024
Q3
$4.83M Buy
68,700
+55,000
+401% +$4.6M ﹤0.01% 2876
2024
Q2
$1.13M Sell
13,700
-17,800
-57% -$1.48M ﹤0.01% 4018
2024
Q1
$2.75M Sell
31,500
-31,500
-50% -$2.82M ﹤0.01% 3454
2023
Q4
$6.07M Buy
63,000
+38,700
+159% +$3.42M 0.01% 2621
2023
Q3
$2.15M Buy
+24,300
New +$2.16M ﹤0.01% 3487
2023
Q2
Sell
-125,300
Closed -$12.2M 6160
2023
Q1
$12.2M Buy
+125,300
New +$13M 0.01% 1768
2020
Q3
Sell
-15,000
Closed -$1.85M 4461
2020
Q2
$1.85M Buy
+15,000
New +$1.49M ﹤0.01% 2598
2014
Q2
Sell
-3,900
Closed -$266K 3416
2014
Q1
$266K Buy
+3,900
New +$287K ﹤0.01% 3008

Other funds holding BMRN